Streamlining of selected non‑strategic early-stage programs completed, consistent with previously announced three-year 2026-2028 strategic plan· No impact on cash runway or financing ...
A recently published Phase I/II clinical trial in the peer-reviewed journal BMC Immunology, and announced by University of ...
BC Platforms, a global leader in healthcare data, technology, and analytics today announced enhancements to BC Mosaic, its AI-powered trusted research environment (TRE), now available on AWS ...
An exploratory drilling project in the La Plata Mountains by Metallic Minerals raises the possibility of a 21st-century ...
Creatv Bio, a Division of Creatv MicroTech, Inc. ("Creatv") has announced the initiation of a collaboration with CytoDyn Inc. of Vancouver, Washington ("CytoDyn") to provide its' LifeTracDx® liquid ...
As the Arctic region becomes increasingly contested, the U.S. military faces a new era of challenges in one of the world's ...
Iovance Biotherapeutics (NASDAQ:IOVA) gains attention in the Nasdaq Index as biotech sentiment and allocation trends shift.
Nipocalimab, an FcRn blocker, receives FDA Fast Track status for SLE treatment after demonstrating significant improvements in disease activity.
R Systems International Limited commissioned, independent research and analysis by Everest Group, and today announced the publication of Agentic AI 2026: A Mid-Market Playbook for ...
Blood lactate levels were associated with survival and weight changes in ALS, according to a study in Australia and Japan.
New research from OHSU points to an unexpected player in cancer research: nerves Ariana Sattler, Ph.D., is first author on a ...
In the future, microexpression analysis could reshape how museums design marketing campaigns and craft exhibition narratives.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results